Efficacy and Safety of Intravenous Lidocaine Versus Placebo in Patients Receiving Morphine-rachi Analgesia

Trial statusNot yet recruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age18+
SponsorGCS Ramsay Santé pour l'Enseignement et la Recherche

About this trial

The purpose of this study is to evaluate the superiority of IV lidocaine combined with morphine spinal anesthesia versus placebo combined with morphine spinal anesthesia, in reducing postoperative morphine consumption at 48 hours, in patients undergoing major digestive or abdominal surgery by laparotomy.

Eligibility criteria

Qualifiers

Age ≥ 18 years;

Major digestive or abdominal surgery (pancreatic, hepatic, colorectal, gynecological, esophageal, gastric, duodenal, small intestine...);

Scheduled surgery;

Laparotomy;

Disqualifiers

Emergency surgery;

Contraindication to non-steroidal anti-inflammatory drugs: history of gastro duodenal ulcer, renal failure from stage 3 A or higher;

History of bradycardia and/or known conduction disorder (atrioventricular block) / Pacemaker ;

Unstable coronary ;

Trial design

Treatments tested in this trial

  • rachi morphine anesthesia
  • laparotomy
  • Lidocaine IV
  • Placebo
  • MORPHINE

Treatment groups

76 Participants
are divided into 2 treatment groups

Sponsors and collaborators